Literature DB >> 17522612

Prospective study of coffee consumption and risk of Parkinson's disease.

K Sääksjärvi1, P Knekt, H Rissanen, M A Laaksonen, A Reunanen, S Männistö.   

Abstract

OBJECTIVE: To examine the prediction of coffee consumption on the incidence of Parkinson's disease. SUBJECTS AND METHODS: The study population comprised 6710 men and women, aged 50-79 years and free from Parkinson's disease at the baseline. At baseline, enquiries were made about coffee consumption in a self-administered questionnaire as the average number of cups per day. During a 22-year follow-up, 101 incident cases of Parkinson's disease occurred. Parkinson's disease cases were identified through a nationwide registry of patients receiving medication reimbursement, which is based on certificates from neurologist.
RESULTS: After adjustments for age, sex, marital status, education, community density, alcohol consumption, leisure-time physical activity, smoking, body mass index, hypertension and serum cholesterol, the relative risk for subjects drinking 10 or more cups of coffee per day compared with non-drinkers was 0.26 (95% confidence interval 0.07-0.99, P-value for trend=0.18). The association was stronger among overweight persons and among persons with lower serum cholesterol level (P-value for interaction=0.04 and 0.03, respectively).
CONCLUSIONS: The results support the hypothesis that coffee consumption reduces the risk of Parkinson's disease, but protective effect of coffee may vary by exposure to other factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17522612     DOI: 10.1038/sj.ejcn.1602788

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  46 in total

1.  Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk.

Authors:  Iris Y Kim; Éilis J O'Reilly; Katherine C Hughes; Xiang Gao; Michael A Schwarzschild; Marjorie L McCullough; Marian T Hannan; Rebecca A Betensky; Alberto Ascherio
Journal:  Mov Disord       Date:  2018-01-10       Impact factor: 10.338

Review 2.  Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Authors:  Marie Therese Armentero; Annalisa Pinna; Sergi Ferré; José Luis Lanciego; Christa E Müller; Rafael Franco
Journal:  Pharmacol Ther       Date:  2011-07-23       Impact factor: 12.310

3.  Reduced risk of Parkinson's disease associated with lower body mass index and heavy leisure-time physical activity.

Authors:  Katri Sääksjärvi; Paul Knekt; Satu Männistö; Jukka Lyytinen; Tuija Jääskeläinen; Noora Kanerva; Markku Heliövaara
Journal:  Eur J Epidemiol       Date:  2014-03-16       Impact factor: 8.082

4.  Enhanced phosphatase activity attenuates α-synucleinopathy in a mouse model.

Authors:  Kang-Woo Lee; Walter Chen; Eunsung Junn; Joo-Young Im; Hilary Grosso; Patricia K Sonsalla; Xuyan Feng; Neelanjana Ray; Jose R Fernandez; Yang Chao; Eliezer Masliah; Michael Voronkov; Steven P Braithwaite; Jeffry B Stock; M Maral Mouradian
Journal:  J Neurosci       Date:  2011-05-11       Impact factor: 6.167

5.  Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: Results from five cohort studies.

Authors:  Elinor Fondell; É Ilis J O'Reilly; Kathryn C Fitzgerald; Guido J Falcone; Laurence N Kolonel; Yikyung Park; Susan M Gapstur; Alberto Ascherio
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-03-30       Impact factor: 4.092

6.  Coffee drinking and pancreatic cancer risk: a meta-analysis of cohort studies.

Authors:  Jie Dong; Jian Zou; Xiao-Feng Yu
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

Review 7.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

8.  Association of Coffee Consumption With Total and Cause-Specific Mortality in 3 Large Prospective Cohorts.

Authors:  Ming Ding; Ambika Satija; Shilpa N Bhupathiraju; Yang Hu; Qi Sun; Jiali Han; Esther Lopez-Garcia; Walter Willett; Rob M van Dam; Frank B Hu
Journal:  Circulation       Date:  2015-11-16       Impact factor: 29.690

Review 9.  Adenosine signaling and function in glial cells.

Authors:  D Boison; J-F Chen; B B Fredholm
Journal:  Cell Death Differ       Date:  2009-09-18       Impact factor: 15.828

10.  Dietary and lifestyle variables in relation to incidence of Parkinson's disease in Greece.

Authors:  Andreas Kyrozis; Apostolia Ghika; Panayiotis Stathopoulos; Dimitris Vassilopoulos; Dimitrios Trichopoulos; Antonia Trichopoulou
Journal:  Eur J Epidemiol       Date:  2013-02-02       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.